Overview

A Study of the Treatment of Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
To compare the effect of treatment with teriparatide with that of salmon calcitonin in postmenopausal women with osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Calcitonin
Calcitonin Gene-Related Peptide
Katacalcin
Salmon calcitonin
Teriparatide